MedTrace Logo

Posterior Reversible Encephalopathy Syndrome in the Critically Ill Patients

NCT03470467 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2019-08-08

No results posted yet for this study

Summary

Posterior Reversible Encephalopathy Syndrome prospective (PRES) registry. Data collection using a standardized form : demographic data and data related to the PRES, including circumstances of onset, dates and times of onset and of symptoms control, on-scene clinical findings, clinical and radiological features of PRES, pre-hospital and hospital care providers, timing of antiepileptic, antihypertensive drugs and supportive treatments, results of etiological investigations, cause of PRES, type and dosage of antiepileptic and antihypertensive drugs. Dates and times of EEG monitoring, EEG results, radiological and biological investigations. Outcomes including vital status and Glasgow Outcome Scale score at ICU and hospital discharge, day-90 and 1-year after SE and determined based on data in the ICU and/or neurologist charts and/or patients phone interview

Conditions

  • Posterior Reversible Encephalopathy Syndrome

Interventions

OTHER

No intervention

No intervention planed

Sponsors & Collaborators

  • Versailles Hospital

    collaborator OTHER

  • Ictal Group

    lead OTHER

Principal Investigators

  • Stephane LEGRIEL, MD · Ictal Group

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-09
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03470467 on ClinicalTrials.gov